The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Viridian Therapeutics, Inc.(NASDAQ:VRDN) 
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody for the treatment of thyroid eye disease; VRDN-002, a biosuperior IGF-1R antibody; and VRDN-003, an IGF-1R antibod...
Share this website to your friends
Viridian Therapeutics . Days Payable Outstanding ttm (DPO)
Viridian Therapeutics . Days Receivable Outstanding ttm (DSO)
Viridian Therapeutics . Op Cashflow Per Share ttm
Viridian Therapeutics . Free Cashflow Per Share ttm
Viridian Therapeutics . Cash Per Share ttm
Viridian Therapeutics . P/S ratio ttm
Viridian Therapeutics . (GAAP) P/E ratio ttm
Viridian Therapeutics . P/B ratio ttm
No extra charts and metrics for this ticker.